Replies to post #123151 on Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

Not exactly, he said it's worth $100 million now. The market opportunity is $500 million plus global opportunities. Second generation brings that opportunity to $2 billion.

http://wsw.com/webcast/seethru15/ambs/


You are entitled to your opinion but don't get to make up facts.

[JPetroInc]

ESS is a last ditch effort to bail water from a sinking ship

and in addition to LymPro & MSPrecise, Gerald stated they were seeking to spin ESS off as well

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120700727&txt2find=ESS

that just leaves MANF, Eltoprazene, PhenoGuard & the GeorgeTown Assays

forget NuroPro and SeraPro, their both completely worthless

AMBS is imploding under the crushing weight of massive convertibles

and there seems to be no way out from underneath it

the FDA isn't giving out many Rare Pediatric Disease Designation (RPDD) vouchers for orphan drugs anymore

and I think Gerald & the esteemed BOD intuitively know their in over their heads

and have been strategizing for the exits...

AJMHO